BrickBio, Inc: BrickBio Inks ADC Co-Development Deal
To co-develop a therapeutic antibody drug conjugate (ADC) with a large pharmaceutical company.
Read full article »
BrickBio develops a SaaS-based platform that provides protein bioconjugation services.
Read more